12.07.2015 Views

Seattle University Collaborative Projects - International Academy of ...

Seattle University Collaborative Projects - International Academy of ...

Seattle University Collaborative Projects - International Academy of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Working to Results in the TBSAart Goosensen, Tilburg <strong>University</strong> (aartgoosensen@kpnmail.nl)Karel Oei, Tilburg <strong>University</strong> (t.i.oei@tilburguniversity.edu)The number <strong>of</strong> psychiatric detention TBS has decreased from 226 to 99 since 2004. The mostimportant reason is that the duration <strong>of</strong> the treatment has exploded (4 years in 2000 to 9 years in2012). In court this dilemma has <strong>of</strong>ten been solved in a resourceful way. At the moment half <strong>of</strong>the (un)conditional termination patients are still in the clinic. And after one year conditionaltermination subsequently results in an unconditional termination. A qualified interaction betweentreatment and risk assessment for release is hardly known. To arrive at a recognizable treatmentmethod for all actors in the TBS-sector, treatment is aimed at the dynamic risk factors <strong>of</strong> theHKT-30. The physical journey and release plan are fixed within four months, as is the exit target(also in terms <strong>of</strong> HKT-30). Competences per discipline or module are balanced out against riskfactors to support the decision <strong>of</strong> how to treat tension between the actual score and target score.Therefore the treatment plan can be explained in less words; the pr<strong>of</strong>essional understands thesense <strong>of</strong> “his” risk factor. This and more has been developed in the route card, valued by the Ist(inspection) as best-practice.Side effects <strong>of</strong> Androgen Deprivation Therapy in the TBSJelle A. Troelstra, Van der Hoevenkliniek, Utrecht, Netherlands (jtroelstra@hoevenkliniek.nl)Karel Oei, Tilburg <strong>University</strong> (t.i.oei@tilburguniversity.edu)The goal <strong>of</strong> Androgen Deprivation Treatment in sex <strong>of</strong>fenders is to reduce the availability <strong>of</strong>testosterone. If the testosterone level declines, a man produces less estrogen. The resulting dropin estrogen production leads to mental and physical complaints. These are complaints thatresemble climacteric complaints: mood swings with depressive complaints, sweat attacks (hotflushes) and osteoporosis. The decline in testosterone can reduce muscle mass and may causecomplaints <strong>of</strong> fatigue. Using progestagene substances such as cyproterone acetate or MPA cancause weight gain and breast enlargement (gynecomastia) as adverse side effects. To preventosteoporosis, patients use calcium tablets, vitamin D and a bisphosphonate. Bone densitymeasurement by DEXA scan takes place at regular intervals. The psychiatrist supervising thetreatment will constantly make comparative assessments <strong>of</strong> the desired effects and the burdens <strong>of</strong>adverse reactions that may occur. When a patient has a desire to have sex with an approvingadult partner, there will not be much resistance from the team that treats the patient. For a patientwith hypersexuality or a patient with a non-exclusive paraphilic sexual preference, such a sexualdesire can fit within a positive life plan. When such a patient starts a relationship with an adultpartner one can consider a milder form <strong>of</strong> antilibidinal medication.386

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!